Cargando…
Antimicrobial Usages and Antimicrobial Resistance in Commensal Escherichia coli From Veal Calves in France: Evolution During the Fattening Process
Extended-Spectrum-Cephalosporin (ESC)-resistant Enterobacteriaceae have widely spread in all settings worldwide. In animals, Extended-Spectrum Beta-Lactamase (ESBL) producers have been frequently identified in veal calves. The objectives of this study were to investigate the trends in the ESBL load...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6473463/ https://www.ncbi.nlm.nih.gov/pubmed/31031738 http://dx.doi.org/10.3389/fmicb.2019.00792 |
_version_ | 1783412436433371136 |
---|---|
author | Gay, Emilie Bour, Maxime Cazeau, Géraldine Jarrige, Nathalie Martineau, Christophe Madec, Jean-Yves Haenni, Marisa |
author_facet | Gay, Emilie Bour, Maxime Cazeau, Géraldine Jarrige, Nathalie Martineau, Christophe Madec, Jean-Yves Haenni, Marisa |
author_sort | Gay, Emilie |
collection | PubMed |
description | Extended-Spectrum-Cephalosporin (ESC)-resistant Enterobacteriaceae have widely spread in all settings worldwide. In animals, Extended-Spectrum Beta-Lactamase (ESBL) producers have been frequently identified in veal calves. The objectives of this study were to investigate the trends in the ESBL load and antimicrobial resistance (AMR) proportions, and antimicrobial usages (AMU) in veal calves during the fattening process. Ten fattening farms were selected and 50 animals per farm were sampled. AMR was assessed in bacteria from the dominant flora (collected on non-selective MacConckey agar) and in ESBL/AmpC-carrying bacteria from the subdominant flora (selected on ChromID ESBL selective plates) upon arrival and 5–6 months later before slaughter. The number and types of treatments during fattening were also collected. Rates of ESBL-producing E. coli from the subdominant flora significantly decreased in all farms (arrival: 67.7%; departure: 20.4%) whereas rates of multidrug-resistant E. coli from the dominant flora have significantly increased (arrival: 60.2%; departure: 67.2%; p = 0.025). CTX-M-1 was the most frequently identified ESBL enzyme (arrival: 59.3%; departure: 52.0%). The plasmid-mediated mcr-1 gene was also identified occasionally. In parallel, levels of resistances to non-critically important antimicrobials were already high upon arrival but have still further increased over time until slaughter. Our study also highlighted that if only ESBL-producing isolates were monitored, it might have led to a partial (and partly false) picture of AMR rates globally decreasing during the fattening period. The mean number of antimicrobial treatments per calf (NTPC) was 8.75 but no association between AMU and AMR was evidenced. Most ESBL producers were clonally unrelated suggesting multiple sources and not cross-contaminations among calves during transportation. Feeding milk containing antimicrobial residues to veal calves is hypothesized to explain the high ESBL loads in animals at the entrance on farms. |
format | Online Article Text |
id | pubmed-6473463 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-64734632019-04-26 Antimicrobial Usages and Antimicrobial Resistance in Commensal Escherichia coli From Veal Calves in France: Evolution During the Fattening Process Gay, Emilie Bour, Maxime Cazeau, Géraldine Jarrige, Nathalie Martineau, Christophe Madec, Jean-Yves Haenni, Marisa Front Microbiol Microbiology Extended-Spectrum-Cephalosporin (ESC)-resistant Enterobacteriaceae have widely spread in all settings worldwide. In animals, Extended-Spectrum Beta-Lactamase (ESBL) producers have been frequently identified in veal calves. The objectives of this study were to investigate the trends in the ESBL load and antimicrobial resistance (AMR) proportions, and antimicrobial usages (AMU) in veal calves during the fattening process. Ten fattening farms were selected and 50 animals per farm were sampled. AMR was assessed in bacteria from the dominant flora (collected on non-selective MacConckey agar) and in ESBL/AmpC-carrying bacteria from the subdominant flora (selected on ChromID ESBL selective plates) upon arrival and 5–6 months later before slaughter. The number and types of treatments during fattening were also collected. Rates of ESBL-producing E. coli from the subdominant flora significantly decreased in all farms (arrival: 67.7%; departure: 20.4%) whereas rates of multidrug-resistant E. coli from the dominant flora have significantly increased (arrival: 60.2%; departure: 67.2%; p = 0.025). CTX-M-1 was the most frequently identified ESBL enzyme (arrival: 59.3%; departure: 52.0%). The plasmid-mediated mcr-1 gene was also identified occasionally. In parallel, levels of resistances to non-critically important antimicrobials were already high upon arrival but have still further increased over time until slaughter. Our study also highlighted that if only ESBL-producing isolates were monitored, it might have led to a partial (and partly false) picture of AMR rates globally decreasing during the fattening period. The mean number of antimicrobial treatments per calf (NTPC) was 8.75 but no association between AMU and AMR was evidenced. Most ESBL producers were clonally unrelated suggesting multiple sources and not cross-contaminations among calves during transportation. Feeding milk containing antimicrobial residues to veal calves is hypothesized to explain the high ESBL loads in animals at the entrance on farms. Frontiers Media S.A. 2019-04-12 /pmc/articles/PMC6473463/ /pubmed/31031738 http://dx.doi.org/10.3389/fmicb.2019.00792 Text en Copyright © 2019 Gay, Bour, Cazeau, Jarrige, Martineau, Madec and Haenni. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Microbiology Gay, Emilie Bour, Maxime Cazeau, Géraldine Jarrige, Nathalie Martineau, Christophe Madec, Jean-Yves Haenni, Marisa Antimicrobial Usages and Antimicrobial Resistance in Commensal Escherichia coli From Veal Calves in France: Evolution During the Fattening Process |
title | Antimicrobial Usages and Antimicrobial Resistance in Commensal Escherichia coli From Veal Calves in France: Evolution During the Fattening Process |
title_full | Antimicrobial Usages and Antimicrobial Resistance in Commensal Escherichia coli From Veal Calves in France: Evolution During the Fattening Process |
title_fullStr | Antimicrobial Usages and Antimicrobial Resistance in Commensal Escherichia coli From Veal Calves in France: Evolution During the Fattening Process |
title_full_unstemmed | Antimicrobial Usages and Antimicrobial Resistance in Commensal Escherichia coli From Veal Calves in France: Evolution During the Fattening Process |
title_short | Antimicrobial Usages and Antimicrobial Resistance in Commensal Escherichia coli From Veal Calves in France: Evolution During the Fattening Process |
title_sort | antimicrobial usages and antimicrobial resistance in commensal escherichia coli from veal calves in france: evolution during the fattening process |
topic | Microbiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6473463/ https://www.ncbi.nlm.nih.gov/pubmed/31031738 http://dx.doi.org/10.3389/fmicb.2019.00792 |
work_keys_str_mv | AT gayemilie antimicrobialusagesandantimicrobialresistanceincommensalescherichiacolifromvealcalvesinfranceevolutionduringthefatteningprocess AT bourmaxime antimicrobialusagesandantimicrobialresistanceincommensalescherichiacolifromvealcalvesinfranceevolutionduringthefatteningprocess AT cazeaugeraldine antimicrobialusagesandantimicrobialresistanceincommensalescherichiacolifromvealcalvesinfranceevolutionduringthefatteningprocess AT jarrigenathalie antimicrobialusagesandantimicrobialresistanceincommensalescherichiacolifromvealcalvesinfranceevolutionduringthefatteningprocess AT martineauchristophe antimicrobialusagesandantimicrobialresistanceincommensalescherichiacolifromvealcalvesinfranceevolutionduringthefatteningprocess AT madecjeanyves antimicrobialusagesandantimicrobialresistanceincommensalescherichiacolifromvealcalvesinfranceevolutionduringthefatteningprocess AT haennimarisa antimicrobialusagesandantimicrobialresistanceincommensalescherichiacolifromvealcalvesinfranceevolutionduringthefatteningprocess |